LPL Financial
IMVT icon

LPL Financial’s Immunovant IMVT Stock Holding History

LPL Financial’s Portfolio IMVT Stock Details IMVT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q3 		– Sell
-8,848
Closed -$234K – 5234
2024
Q2 		$234K Buy
8,848
+535
+6% +$15.2K ﹤0.01% 4452
2024
Q1 		$269K Sell
8,313
-1,777
-18% -$64.8K ﹤0.01% 4290
2023
Q4 		$425K Buy
10,090
+96
+1% +$3.53K ﹤0.01% 3790
2023
Q3 		$384K Buy
+9,994
New +$226K ﹤0.01% 3700

Other funds holding IMVT

Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
DTC
Deep Track Capital Greenwich, Connecticut $6.12B AUM 144% 1-Year Est. Return
AC
Armistice Capital New York $5.62B AUM 36.06% 1-Year Est. Return
T. Rowe Price Investment Management
T. Rowe Price Investment Management Baltimore, Maryland $145B AUM 22.78% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
PA
Perceptive Advisors New York $5.12B AUM 314.02% 1-Year Est. Return
Viking Global Investors
Viking Global Investors Stamford, Connecticut $35.7B AUM 21.3% 1-Year Est. Return
AGM
Alpine Global Management New York $668M AUM 20.22% 1-Year Est. Return

LPL Financial's IMVT Position: Q3 2024 in Review

LPL Financial sold out of Immunovant (IMVT) in Q3 2024, closing a stake of 8,848 shares — an estimated $234K sold.

LPL Financial first reported a position in IMVT in Q3 2023 and held it in 4 quarters. The position peaked at $425K in Q4 2023. 181 funds tracked by Wall St. Rank hold IMVT as of Q3 2024.

  • LPL Financial reported no remaining Immunovant position as of Q3 2024 after selling out during the quarter.
  • LPL Financial sold 8,848 Immunovant shares in Q3 2024, an estimated $234K.
  • LPL Financial first reported a position in Immunovant in Q3 2023 and held it in 4 quarters.
  • LPL Financial's Immunovant position peaked at $425K in Q4 2023.
  • 181 funds tracked by Wall St. Rank held Immunovant as of Q3 2024.

Based on LPL Financial's 13F filing for Q3 2024, filed 8 Nov 2024.